MARKETING & SALES EUROPE - OMI’s NEXT FRONTIER We have previously flagged the expectation of our appointment of a new syringe distributor for Europe. This process has taken longer than expected, but will create significant value for OMI, its shareholders and its new, market leading, distributor. We have successfully completed clinical trials, audits of the manufacturing facility and extensive quality reviews bringing us to the final steps of now concluding details of both the contract and Private Label packaging. We look forward to officially announcing details of this incredibly exciting next step in OMI’s global sales strategy in the coming weeks.
ICU Price at posting:
19.0¢ Sentiment: LT Buy Disclosure: Held
